Signature ID'd for Allergen-Specific Type 2 Helper Cells

Share this content:
Signature ID'd for Allergen-Specific Type 2 Helper Cells
Signature ID'd for Allergen-Specific Type 2 Helper Cells

WEDNESDAY, Aug. 2, 2017 (HealthDay News) -- In research published in the Aug. 2 issue of Science Translational Medicine, scientists have identified a human type 2 helper (TH2) cell signature in allergen-specific TH2 cells.

Noting that use of atopic disease-causing T cells as therapeutic targets and clinically useful biomarkers is limited by lack of an accepted methodology to identify and differentiate these cells from nonpathogenic TH2 cell types, Erik Wambre, Ph.D., from the Benaroya Research Institute in Seattle, and colleagues present data on a subset of human memory TH2 cells confined to atopic individuals that included all allergen-specific TH2 cells.

The researchers found that the subset of cells was made up of terminally differentiated CD4+ T cells, which were characterized by coexpression of CRTH2, CD49d, and CD161; they also exhibited functional attributes that were distinct from conventional TH2 cells. Cells with this allergic disease-related phenotype were designated as the TH2A cell subset. In transcriptome analysis, a distinct pathway was identified in the initiation of pathogenic responses to allergen; elimination of these cells indicated immunotherapy-induced clinical responses.

"Together, these findings identify a human TH2 cell signature in allergic diseases that could be used for response-monitoring and designing appropriate immunomodulatory strategies," the authors write.

Two authors are listed as inventors on patents held or submitted by the Benaroya Research Institute.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Zika Does Not Appear to Last in Semen As Long As Thought

Zika Does Not Appear to Last in Semen ...

More research is needed to better inform public health recommendations

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke Risk

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke ...

I-131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke

Higher Odds of Infection With Reduced Kidney Function

Higher Odds of Infection With Reduced Kidney Function

Study finds excess community-acquired infections incidence in individuals with mild to severe CKD

is free, fast, and customized just for you!

Already a member?

Sign In Now »